These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1329 related articles for article (PubMed ID: 10411935)
1. CpG island methylator phenotype in colorectal cancer. Toyota M; Ahuja N; Ohe-Toyota M; Herman JG; Baylin SB; Issa JP Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8681-6. PubMed ID: 10411935 [TBL] [Abstract][Full Text] [Related]
2. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci. Kawasaki T; Ohnishi M; Nosho K; Suemoto Y; Kirkner GJ; Meyerhardt JA; Fuchs CS; Ogino S Mod Pathol; 2008 Mar; 21(3):245-55. PubMed ID: 18204436 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853 [TBL] [Abstract][Full Text] [Related]
5. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer. Wong JJ; Hawkins NJ; Ward RL; Hitchins MP Mod Pathol; 2011 Mar; 24(3):396-411. PubMed ID: 21102416 [TBL] [Abstract][Full Text] [Related]
6. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter. Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773 [TBL] [Abstract][Full Text] [Related]
8. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837 [TBL] [Abstract][Full Text] [Related]
9. Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer. Deng G; Peng E; Gum J; Terdiman J; Sleisenger M; Kim YS Br J Cancer; 2002 Feb; 86(4):574-9. PubMed ID: 11870540 [TBL] [Abstract][Full Text] [Related]
10. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226 [TBL] [Abstract][Full Text] [Related]
11. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer. Iacopetta B; Grieu F; Li W; Ruszkiewicz A; Caruso M; Moore J; Watanabe G; Kawakami K Int J Cancer; 2006 Nov; 119(10):2272-8. PubMed ID: 16981189 [TBL] [Abstract][Full Text] [Related]
12. CpG island methylation in colorectal adenomas. Rashid A; Shen L; Morris JS; Issa JP; Hamilton SR Am J Pathol; 2001 Sep; 159(3):1129-35. PubMed ID: 11549606 [TBL] [Abstract][Full Text] [Related]
13. CpG island methylator phenotypes in aging and cancer. Toyota M; Issa JP Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343 [TBL] [Abstract][Full Text] [Related]
14. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Toyota M; Ohe-Toyota M; Ahuja N; Issa JP Proc Natl Acad Sci U S A; 2000 Jan; 97(2):710-5. PubMed ID: 10639144 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Ashktorab H; Smoot DT; Farzanmehr H; Fidelia-Lambert M; Momen B; Hylind L; Iacosozio-Dononue C; Carethers JM; Goel A; Boland CR; Giardiello FM Int J Cancer; 2005 Oct; 116(6):914-9. PubMed ID: 15856472 [TBL] [Abstract][Full Text] [Related]
16. Genetics supersedes epigenetics in colon cancer phenotype. Yamashita K; Dai T; Dai Y; Yamamoto F; Perucho M Cancer Cell; 2003 Aug; 4(2):121-31. PubMed ID: 12957287 [TBL] [Abstract][Full Text] [Related]
17. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer. Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745 [TBL] [Abstract][Full Text] [Related]
19. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Deng G; Chen A; Hong J; Chae HS; Kim YS Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580 [TBL] [Abstract][Full Text] [Related]
20. The epigenetics of colorectal cancer. Issa JP Ann N Y Acad Sci; 2000 Jun; 910():140-53; discussion 153-5. PubMed ID: 10911911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]